Search Results

Apolipoprotein C-III in association with metabolic-dysfunction associated steatotic liver disease: A large, multicenter study.

• Authors : Kouvari, Matina; Valenzuela-Vallejo, Laura; Guatibonza-Garcia, Valentina

• Source: Clinical Nutrition; Dec2024, Vol. 43 Issue 12, p101-108, 8p

Record details

Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophy.

• Authors : Lightbourne, Marissa; Startzell, Megan; Bruce, Kimberley D.

Subjects: LIPOPROTEINS; TRIGLYCERIDES; LIPODYSTROPHY

• Source: Journal of Clinical Lipidology; Nov2022, Vol. 16 Issue 6, p850-862, 13p

Record details

Simultaneous Quantification of Apolipoprotein C‑III O‑Glycoforms by Protein-MRM.

• Authors : Kim, Hyojin; Cheon, Dong Huey; Yang, Won Suk

• Source: Journal of Proteome Research; 1/6/2023, Vol. 22 Issue 1, p91-100, 10p

Record details

Aberrant apolipoprotein C-III glycosylation in glycogen storage disease type III and IX.

• Authors : Ondruskova, Nina; Honzik, Tomas; Kolarova, Hana

Subjects: APOLIPOPROTEIN C; GLYCOSYLATION; GLYCOGEN storage disease

• Source: Metabolism: Clinical & Experimental; May2018, Vol. 82, p135-141, 7p

Record details

Apolipoprotein C-I mediates Wnt/Ctnnb1 signaling during neural border formation and is required for neural crest development.

• Authors : CHIKA YOKOTA; ÅSTRAND, CAROLINA; SHUJI TAKAHASHI

Subjects: VERTEBRATES; NEURAL crest; PLACODES

• Source: International Journal of Developmental Biology; 2017, Vol. 61 Issue 6/7, p415-425, 11p, 2 Color Photographs, 5 Graphs

Record details

Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors

• Authors : Spagnuolo, Catherine M; Hegele, Robert A

• Source: Expert Opinion on Pharmacotherapy; June 2023, Vol. 24 Issue: 9 p1013-1020, 8p

Record details

Apolipoprotein C proteins in plasma non‐high‐density lipoprotein fractions and development of Alzheimer's disease, central arterial stiffness, and cerebral small vessel disease in older adults.

• Authors : Glittenberg, Matthew; Flaten, Zachery; Kumar, Sai Kaushik Shankar Ramesh

• Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Jun2023 Supplement 1, Vol. 19, p1-2, 2p

Record details

RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia.

• Authors : Gaudet, Daniel; Clifton, Peter; Sullivan, David

Subjects: DRUG therapy for hyperlipidemia; RNA physiology; TRIGLYCERIDES

• Source: NEJM Evidence; Dec2023, Vol. 2 Issue 12, p7-7, 1p

Record details

Simultaneous Quantification of Apolipoprotein C-III O-Glycoforms by Protein-MRM

• Authors : Kim, Hyojin; Cheon, Dong Huey; Yang, Won Suk

• Source: Journal of Proteome Research; January 2023, Vol. 22 Issue: 1 p91-100, 10p

Record details

Apolipoprotein C-III Inhibition -- Killing Two Birds with One Stone?

• Authors : Kraaijenhof, Jordan M.; Stroes, Erik S. G.

Subjects: APOLIPOPROTEINS; CHEMICAL inhibitors

• Source: NEJM Evidence; Dec2023, Vol. 2 Issue 12, p1-1, 1p

Record details